{"id":2642,"date":"2019-10-07T13:13:13","date_gmt":"2019-10-07T11:13:13","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=2642"},"modified":"2024-06-06T17:25:03","modified_gmt":"2024-06-06T15:25:03","slug":"genetica-molecular-humana","status":"publish","type":"page","link":"https:\/\/idibell.cat\/recerca\/area-de-medicina-translacional\/programa-de-gens-malaltia-i-terapia\/genetica-molecular-humana\/","title":{"rendered":"Gen\u00e8tica molecular humana"},"content":{"rendered":"\n<h1>\n\t\tGen\u00e8tica molecular humana\n\t<\/h1>\n<h3>\n\t\tResum\n\t<\/h3>\n\t<p>El grup de gen\u00e8tica molecular humana t\u00e9 com a objectiu principal comprendre millor les bases gen\u00e8tiques i moleculars de les malalties monog\u00e8niques o complexes heredit\u00e0ries i\/o els processos immunoinflamatoris utilitzant estrat\u00e8gies d&#8217;alt rendiment, com ara la gen\u00f2mica, la transcript\u00f2mica i la prote\u00f2mica, aix\u00ed com aproximacions funcionals i estructurals per tal de discernir les caracter\u00edstiques cl\u00edniques i patol\u00f2giques dels trastorns rars. A m\u00e9s, treballen per desenvolupar noves ter\u00e0pies moleculars\/cel\u00b7lulars. La multidisciplinarietat del grup els permet enriquir el focus experimental dels seus projectes de recerca.<\/p>\n<h2>419<\/h2>\n<h2>Publicacions<\/h2>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2019\/05\/grup_sense_foto_-_gens.jpg\" alt=\"grup_sense_foto_-_gens\" itemprop=\"image\" height=\"300\" width=\"600\" title=\"grup_sense_foto_-_gens\" onerror=\"this.style.display='none'\"  \/>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-0\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-0\">L\u00ednies estrat\u00e8giques<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-0\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-0\"><i>Expand<\/i><\/a>\n\t\t\t\t\t<ul>\n<li><strong>Gen\u00e8tica molecular de malalties urogenitals.<\/strong>\u00a0IP: Sara Larriba. Aquesta l\u00ednia de recerca se centra en la comprensi\u00f3 dels mecanismes gen\u00e8tics i epigen\u00e8tics implicats en trastorns urogenitals masculins. Concretament, un dels nostres projectes tracta de l&#8217;an\u00e0lisi del mecanisme de transcriptoma i la regulaci\u00f3 de l&#8217;expressi\u00f3 g\u00e8nica dels teixits en les malalties. Aquest estudi es complementa amb la identificaci\u00f3 de nous biomarcadors gen\u00e8tics no invasius, \u00fatils per al diagn\u00f2stic i el pron\u00f2stic de patologies urogenitals.<\/li>\n<li><strong>Bases moleculars de les malalties heredit\u00e0ries: Cistin\u00faria, Malalties associades a mutacions en transportadors d&#8217;amino\u00e0cids, leucoencefalopatia megalenc\u00e8pica amb quists subcorticals (MLC) i s\u00edndrome de Wolfram.<\/strong>\u00a0IP: Virginia Nunes. Aquesta l\u00ednia de recerca se centra en: i) la comprensi\u00f3 de la reabsorci\u00f3 d&#8217;amino\u00e0cids renals, ii) la identificaci\u00f3 de noves malalties associades amb alteracions en el transport d&#8217;amino\u00e0cids (sordesa i cataractes), iii) la determinaci\u00f3 de nous factors gen\u00e8tics que ajuden a establir les bases moleculars de les malalties esmentades i buscar possibles estrat\u00e8gies terap\u00e8utiques, utilitzant models de ratolins knockout com a eina.<\/li>\n<li><strong>C\u00e0ncer i resposta immune: Desenvolupament de nous immunosupressors i agents antitumorals terap\u00e8utics<\/strong>. IP: Merc\u00e8 P\u00e9rez. Aquesta l\u00ednia de recerca es centra a determinar l&#8217;efecte funcional i terap\u00e8utic de les prote\u00efnes RCAN en la progressi\u00f3 del tumor i la met\u00e0stasi en el c\u00e0ncer de mama triple negatiu. D&#8217;altra banda, el nostre grup va identificar 6 hits, petites mol\u00e8cules no pept\u00eddiques que imiten l&#8217;efecte funcional de RCAN, que s&#8217;estan millorant per obtenir els estrat\u00e8gies\u00a0que seran avaluades\u00a0<em>in vivo\u00a0<\/em>per determinar la seva efic\u00e0cia terap\u00e8utica immunosupressiva i antitumoral.<\/li>\n<li><strong>Estructura y fisiopatolog\u00eda de los transportadores SLC:<\/strong> IP: Ekaitz Errasti Murugarren. Esta l\u00ednea de investigaci\u00f3n se centra en la comprensi\u00f3n de los transportadores Solute carrier (SLC), desde un punto de vista fisiopatol\u00f3gico, funcional y estructural. En particular, los transportadores de amino\u00e1cidos (familia SLC7) y los transportadores de tipo colina (familia SLC44) son de particular inter\u00e9s como objetivos terap\u00e9uticos potenciales debido a su asociaci\u00f3n con trastornos neurosensoriales y del neurodesarrollo.<\/li>\n<li><strong>Estructura i fisiopatologia dels transportadors SLC:<\/strong> IP: Ekaitz Errasti Murugarren. Aquesta l\u00ednia de recerca se centra en la comprensi\u00f3 dels transportadors Solute carrier (SLC) des d&#8217;un punt de vista fisiopatol\u00f2gic, funcional i estructural. En particular, els transportadors d&#8217;amino\u00e0cids (fam\u00edlia SLC7) i els transportadors de tipus tur\u00f3 (fam\u00edlia SLC44) s\u00f3n de particular inter\u00e8s com a objectius terap\u00e8utics potencials a causa de la seva associaci\u00f3 amb trastorns neurosensorials i del neurodesenvolupament.<\/li>\n<\/ul>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-1\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-1\">Publicacions seleccionades<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-1\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-1\"><i>Expand<\/i><\/a>\n\t\t\t\t\t<ul>\n<li>Mayayo Vallverdu,C;Lopez de Heredia,M;Prat,E;Gonzalez,L;Espino Guarch,M; VILCHES,C;Munoz,L et al, <strong>The antioxidant l-Ergothioneine prevents cystine lithiasis in the Slc7a9-\/- mouse model of cystinuria<\/strong>., Redox Biol., 2023;64102801-102801, doi:10.1016\/j.redox.2023.102801<\/li>\n<li>Ferre,A;Santiago,L;S\u00e1nchez Herrero,JF;L\u00f3pez Rodrigo,O;S\u00e1nchez Curbelo,J;Sumoy,L;Bassas,L et al,<strong> 3&#8217;IsomiR Species Composition Affects Reliable Quantification of miRNA\/isomiR Variants by Poly(A) RT-qPCR: Impact on Small RNA-Seq Profiling Validation<\/strong>, Int. J. Mol. Sci., 2023;24(20):doi:10.3390\/ijms242015436<\/li>\n<li>Mayayo Vallverd\u00fa,C;Prat,E;Vecino P\u00e9rez,M;Gonz\u00e1lez,L;Gr\u00e0cia Garcia,S;San Miguel,L;Lopera,N et al, <strong>Exploring the Contribution of the Transporter AGT1\/rBAT in Cystinuria Progression: Insights from Mouse Models and a Retrospective Cohort Study<\/strong>, Int. J. Mol. Sci., 2023;24(24):doi:10.3390\/ijms242417140<\/li>\n<li>Larriba,S;S\u00e1nchez Herrero,JF;Pluvinet,R;L\u00f3pez Rodrigo,O;Bassas,L;Sumoy,L, <strong>Seminal extracellular vesicle sncRNA sequencing reveals altered miRNA\/isomiR profiles as sperm retrieval biomarkers for azoospermia<\/strong>, Andrology, 2023;12(1):137-156, doi:10.1111\/andr.13461<\/li>\n<li>LARRIBA,S;Vigues,F;Bassas,L, <strong>Using Small Non-Coding RNAs in Extracellular Vesicles of Semen as Biomarkers of Male Reproductive System Health: Opportunities and Challenges<\/strong>., Int. J. Mol. Sci., 2023;24(6):doi:10.3390\/ijms24065447<\/li>\n<\/ul>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-2\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-2\">Projectes seleccionats<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-2\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-2\"><i>Expand<\/i><\/a>\n\t\t\t\t\t<ul>\n<li>21FIS034. <strong>Cistinuria: Validaci\u00f3n de un nuevo biomarcador de litiasis de cistina en pacientes y dise\u00f1o de un nuevo tratamiento, basados en moduladores de la litiasis de cistina identificados en modelos de rat\u00f3n<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 244.420\u20ac. 2021-2024. PI: NUNES MARTINEZ, VIRGINIA.<\/li>\n<li>PNJ21002. <strong>Urine biomarker and reprofiling drug for cystinuria treatment<\/strong>. AVEROA SAS. Budget: 128.463,23\u20ac. 2021-2026. PI: NUNES MART\u00cdNEZ, VIRGINIA.<\/li>\n<li>21MAR004.<strong> Theapeutical strategies for cystinuria. Fundaci\u00f3 La Marat\u00f3 de TV3<\/strong>. Budget: 199.999,99\u20ac. 2021-2025. PI: NUNES MARTINEZ, VIRGINIA.<\/li>\n<li>PUB22028. I<strong>NVESTIGO 2022<\/strong>. SERVICIO PUBLICO DE EMPLEO ESTATAL SEPE. Budget: 66.217,68\u20ac. 2023-2025. PI: Larriba Bartolom\u00e9, Sara.<\/li>\n<li>20PNJ075. <strong>Role of HAT transporter on ILC2 and type II inflammation during obesity and insulin resistance<\/strong>. SIDRA MEDICINE. Budget: 13.164\u20ac. 2020-2023. PI: NUNES MART\u00cdNEZ, VIRGINIA.<\/li>\n<\/ul>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-3\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-3\">Transfer\u00e8ncia de tecnologia<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-3\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-3\"><i>Expand<\/i><\/a>\n\t\t\t\t\tPAT074-Ergothioneine, s-methyl-ergothioneine and uses thereof<br \/>\nIP: Virginia Nunes<br \/>\nOWNERSHIP: 25% IDIBELL 25% UB 50%CIBERER<br \/>\nApplicant: FUNDACI\u00d3 INSTITUT D&#8217;INVESTIGACI\u00d3 BIOM\u00c8DICA DE BELLVITGE (IDIBELL); UNIVERSITAT DE BARCELONA; CONSORCIO CENTRO DE INVESTIGACI\u00d3N BIOM\u00c9DICA EN RED, M.P.\nLicense: Urine biomarker and reprofiling drug for cystinuria treatment and\/or relief<br \/>\nPI: Dra. Virginia Nunes\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-4\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-4\">M\u00e9s informaci\u00f3<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-4\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-4\"><i>Expand<\/i><\/a>\n\t\t\t\t\t<p>El grup ha:<\/p>\nIdentificat i caracteritzat gens responsables de:<br \/>\nCistin\u00faria (SLC3A1 i SLC7A9).<br \/>\nLisin\u00faria amb intoler\u00e0ncia a prote\u00efnes (LPI) (SLC7A7).<br \/>\nLeucoencefalopatia megalencef\u00e0lica amb cistes subcorticals (MLC1) (GlialCAM).<br \/>\nMalalties musculars.<br \/>\nGenerat els models de ratol\u00ed knockout per a cistin\u00faria i MLC1.<br \/>\nContribu\u00eft a la descripci\u00f3 dels fenotips cl\u00ednics i patol\u00f2gics per a les miopaties miofibrilars i tamb\u00e9 per a les miopaties amb agregats de prote\u00efnes.<br \/>\nDescrit noves entitats miol\u00f2giques.<br \/>\nEstablert una correlaci\u00f3 de genotip \/ fenotip per a la S\u00edndrome de Wolfram basada en l&#8217;efecte esperat de les mutacions sobre l&#8217;expressi\u00f3 de prote\u00efnes i la primera taxa de progressi\u00f3 de la malaltia.<br \/>\nParticipat com a soci en el projecte EURO-WABB al Registre Europeu per als s\u00edndromes Alstr\u00f6m, Barder-Biedl i Wolfram, aix\u00ed com en les seves guies cl\u00edniques.<br \/>\nContribu\u00eft a la caracteritzaci\u00f3 molecular dels trastorns espermatog\u00e8nics (identificant variants de seq\u00fc\u00e8ncia associades a la infertilitat, determinant el perfil d&#8217;expressi\u00f3 g\u00e8nica del teixit i estudiant mecanismes de regulaci\u00f3 transcripcional i post-translacional)<br \/>\nContribu\u00eft a la caracteritzaci\u00f3 molecular d&#8217;inhibidors end\u00f2gens de la via de senyalitzaci\u00f3 de calcineurina-NFATc en c\u00e8l\u00b7lules T humanes: la rellev\u00e0ncia fisiol\u00f2gica de les prote\u00efnes RCAN i el seu potencial terap\u00e8utic. Desenvolupament de mol\u00e8cules no pept\u00eddiques que imiten el paper fisiol\u00f2gic de RCAN.\n<p><em>Proyectos financiados por el Instituto de Salud Carlos III (ISCIII) y cofinanciados por el Fondo Europeo de Desarrollo Regional (FEDER):<\/em><\/p>\n<strong>Identificaci\u00f3n de nuevos factores pron\u00f3stico y diagn\u00f3stico de patolog\u00edas urogenitales basados en microRNAs en plasma seminal<br \/>\n<\/strong>PI15\/00905. 01\/2016-12\/2018. 81.500 \u20ac. IP: Sara Larriba Bartolom\u00e9.<br \/>\nProfundizar en el estudio de los niveles de expresi\u00f3n de miRNAs extracelular en semen y evaluar su utilizaci\u00f3n como biomarcador no invasivo en patolog\u00edas urogenitales. La concentraci\u00f3n de ciertos miRNAs (de manera individual y combinada) son capaces de discernir muestras con tumor y sin tumor con una especifidad y sensibilidad suficiente para el dise\u00f1o de un test con utilidad diagn\u00f3stica.\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2019\/12\/7mUdUAq.png\" alt=\"\" width=\"249\" height=\"150\" \/><\/p>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2019\/10\/avatar-188-150x150.jpeg\" alt=\"avatar-188\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"avatar-188\" onerror=\"this.style.display='none'\"  \/>\n<h2>\n\t\tInvestigadors principals\n\t<\/h2>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2022\/06\/Ekaitz-Errasti-Murugarren-150x150.jpg\" alt=\"Ekaitz-Errasti-Murugarren\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Ekaitz-Errasti-Murugarren\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tErrasti Murugarren, Ekaitz\n\t<\/h4>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2022\/11\/Sara-Larriba-22-150x150.jpg\" alt=\"Sara-Larriba-22\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Sara-Larriba-22\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tLarriba Bartolome, Sara\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:slarriba@idibell.cat\" title=\"slarriba@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\tslarriba@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\tENLLA\u00c7OS RELACIONATS\n\t<\/h4>\n<h4>\n\t\t<a href=\"http:\/\/www.ciberer.es\/grupos\/grupo-de-investigacion?id=17118\" title=\"CIBERER U730 (CB06\/07\/0069)\" target=\"_blank\" rel=\"noopener\">\n\t\tCIBERER U730 (CB06\/07\/0069)\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\t<a href=\"http:\/\/www.orpha.net\/consor\/cgi-bin\/OC_Exp.php?Expert=3463\" title=\"Orphanet - Wolfram Syndrome\" target=\"_blank\" rel=\"noopener\">\n\t\tOrphanet &#8211; Wolfram Syndrome\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\t<a href=\"http:\/\/www.euro-wabb.org\/images\/euro-wabb\/guidelines\/Wolfram_guideline_V14_%2028_04_2014.pdf\" title=\"Wolfram Syndrome - guia cl\u00ednica\" target=\"_blank\" rel=\"noopener\">\n\t\tWolfram Syndrome &#8211; guia cl\u00ednica\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\t<a href=\"http:\/\/www.euro-wabb.org\/images\/euro-wabb\/guidelines\/Alstrom_Guideline_V14_%2028_04_2014.pdf\" title=\"Alstr\u00f6m Syndrome - guia cl\u00ednica\" target=\"_blank\" rel=\"noopener\">\n\t\tAlstr\u00f6m Syndrome &#8211; guia cl\u00ednica\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\t<a href=\"http:\/\/www.euro-wabb.org\/images\/euro-wabb\/guidelines\/BardetBiedl_Guideline_V14_28_04_2014.pdf\" title=\"Bardet - Biedl Syndrome - guia cl\u00ednica\" target=\"_blank\" rel=\"noopener\">\n\t\tBardet &#8211; Biedl Syndrome &#8211; guia cl\u00ednica\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\t<a href=\"http:\/\/rht.iconcologia.net\/stats\/br\/\" title=\"Bootstratio application\" target=\"_blank\" rel=\"noopener\">\n\t\tBootstratio application\n\t\t<\/a>\n\t<\/h4>\n<h2>\n\t\tEquip\n\t<\/h2>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-0\" data-index=\"0\" aria-selected=\"true\" aria-controls=\"fl-tabs--panel-0\" aria-expanded=\"true\" role=\"tab\" tabindex=\"0\">\t\t\t\tCaps de grup\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-1\" data-index=\"1\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-1\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tInvestigadors\/es principals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-2\" data-index=\"2\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-2\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tInvestigadors\/es postdoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-3\" data-index=\"3\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-3\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tSuport cient\u00edfic\t\t\t\t<\/a>\n\t\t\t\t\t\tCaps de grup\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Nunes Martinez, Virginia<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadors\/es principals\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Larriba Bartolome, Sara<\/li>\n<li>Errasti Murugarren, Ekaitz<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadors\/es postdoctorals\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Prat Pedrola, Ester<\/li>\n<li>Mayayo Vallverdu, Clara<\/li>\n<\/ul>\n\t\t\t\t\t\tSuport cient\u00edfic\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Vecino P\u00e9rez, Marta<\/li>\n<li>Ferre Giraldo, Adriana<\/li>\n<\/ul>\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/25740\" content=\"Mor Virginia Nunes, cap del grup de Gen\u00e8tica Molecular Humana i una de les fundadores de l'IDIBELL\" \/><meta itemprop=\"datePublished\" content=\"2024-05-25\" \/><meta itemprop=\"dateModified\" content=\"2024-05-25\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2024\/05\/NO67-Nunes_CIBERER-Imatge-Nunes.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/05\/mor-virginia-nunes-cap-del-grup-de-genetica-molecular-humana-i-una-de-les-fundadores-de-lidibell\/\" title=\"Mor Virginia Nunes, cap del grup de Gen\u00e8tica Molecular Humana i una de les fundadores de l'IDIBELL\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/05\/mor-virginia-nunes-cap-del-grup-de-genetica-molecular-humana-i-una-de-les-fundadores-de-lidibell\/\" title=\"Mor Virginia Nunes, cap del grup de Gen\u00e8tica Molecular Humana i una de les fundadores de l'IDIBELL\">Mor Virginia Nunes, cap del grup de Gen\u00e8tica Molecular Humana i una de les fundadores de l&#8217;IDIBELL<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t25\/05\/2024\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/24803\" content=\"Descobreixen potencials biomarcadors per a la infertilitat masculina: la composici\u00f3 dels microRNAs i les seves isoformes\" \/><meta itemprop=\"datePublished\" content=\"2023-12-28\" \/><meta itemprop=\"dateModified\" content=\"2023-12-28\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/12\/DAMBin-scaled.jpg\" \/><meta itemprop=\"width\" content=\"2560\" \/><meta itemprop=\"height\" content=\"1707\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2023\/12\/descobreixen-potencials-biomarcadors-per-a-la-infertilitat-masculina-la-composicio-dels-micrornas-i-les-seves-isoformes\/\" title=\"Descobreixen potencials biomarcadors per a la infertilitat masculina: la composici\u00f3 dels microRNAs i les seves isoformes\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2023\/12\/descobreixen-potencials-biomarcadors-per-a-la-infertilitat-masculina-la-composicio-dels-micrornas-i-les-seves-isoformes\/\" title=\"Descobreixen potencials biomarcadors per a la infertilitat masculina: la composici\u00f3 dels microRNAs i les seves isoformes\">Descobreixen potencials biomarcadors per a la infertilitat masculina: la composici\u00f3 dels microRNAs i les seves isoformes<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t28\/12\/2023\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/23882\" content=\"Els ARNs petits presents al semen \u00fatils com a biomarcadors per determinar l&#8217;origen de l&#8217;azoosp\u00e8rmia\" \/><meta itemprop=\"datePublished\" content=\"2023-06-20\" \/><meta itemprop=\"dateModified\" content=\"2023-06-20\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/06\/NO59-S-Larriba_Andrology-Imatge-noti.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2023\/06\/els-arns-petits-presents-al-semen-utils-com-a-biomarcadors-per-determinar-lorigen-de-lazoospermia\/\" title=\"Els ARNs petits presents al semen \u00fatils com a biomarcadors per determinar l&#8217;origen de l&#8217;azoosp\u00e8rmia\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2023\/06\/els-arns-petits-presents-al-semen-utils-com-a-biomarcadors-per-determinar-lorigen-de-lazoospermia\/\" title=\"Els ARNs petits presents al semen \u00fatils com a biomarcadors per determinar l&#8217;origen de l&#8217;azoosp\u00e8rmia\">Els ARNs petits presents al semen \u00fatils com a biomarcadors per determinar l&#8217;origen de l&#8217;azoosp\u00e8rmia<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t20\/06\/2023\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/22246\" content=\"Confirmen la utilitat d&#8217;un microARN en semen com a biomarcador per al diagn\u00f2stic d'azoospermia\" \/><meta itemprop=\"datePublished\" content=\"2022-10-03\" \/><meta itemprop=\"dateModified\" content=\"2022-10-04\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2022\/10\/NO089-S-Larriba_Andrology-Imatge-noti.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2022\/10\/confirmen-la-utilitat-dun-microarn-en-semen-com-a-biomarcador-per-al-diagnostic-dazoospermia\/\" title=\"Confirmen la utilitat d&#8217;un microARN en semen com a biomarcador per al diagn\u00f2stic d'azoospermia\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2022\/10\/confirmen-la-utilitat-dun-microarn-en-semen-com-a-biomarcador-per-al-diagnostic-dazoospermia\/\" title=\"Confirmen la utilitat d&#8217;un microARN en semen com a biomarcador per al diagn\u00f2stic d'azoospermia\">Confirmen la utilitat d&#8217;un microARN en semen com a biomarcador per al diagn\u00f2stic d&#8217;azoospermia<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t03\/10\/2022\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/21554\" content=\"El genotipat a gran escala permet identificar la causa molecular de dos casos de globozoosp\u00e8rmia familiar\" \/><meta itemprop=\"datePublished\" content=\"2022-06-10\" \/><meta itemprop=\"dateModified\" content=\"2022-06-10\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2022\/06\/NO-S-Larriba_GWAS-Imatge1.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2022\/06\/el-genotipat-a-gran-escala-permet-identificar-la-causa-molecular-de-dos-casos-de-globozoospermia-familiar\/\" title=\"El genotipat a gran escala permet identificar la causa molecular de dos casos de globozoosp\u00e8rmia familiar\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2022\/06\/el-genotipat-a-gran-escala-permet-identificar-la-causa-molecular-de-dos-casos-de-globozoospermia-familiar\/\" title=\"El genotipat a gran escala permet identificar la causa molecular de dos casos de globozoosp\u00e8rmia familiar\">El genotipat a gran escala permet identificar la causa molecular de dos casos de globozoosp\u00e8rmia familiar<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t10\/06\/2022\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/20075\" content=\"Tanquem un 2021 ple de ci\u00e8ncia!\" \/><meta itemprop=\"datePublished\" content=\"2021-12-30\" \/><meta itemprop=\"dateModified\" content=\"2022-01-11\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/12\/NO123-Best-2021-Imatge.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/12\/tanquem-un-2021-ple-de-ciencia\/\" title=\"Tanquem un 2021 ple de ci\u00e8ncia!\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/12\/tanquem-un-2021-ple-de-ciencia\/\" title=\"Tanquem un 2021 ple de ci\u00e8ncia!\">Tanquem un 2021 ple de ci\u00e8ncia!<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t30\/12\/2021\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/19135\" content=\"Identifiquen un possible biomarcador de l&#8217;aparici\u00f3 de pedres en cistin\u00faria\" \/><meta itemprop=\"datePublished\" content=\"2021-09-30\" \/><meta itemprop=\"dateModified\" content=\"2021-09-30\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/09\/graphical-abstract_antioxidants.jpg\" \/><meta itemprop=\"width\" content=\"2200\" \/><meta itemprop=\"height\" content=\"1120\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/09\/identifiquen-un-possible-biomarcador-de-laparicio-de-pedres-en-cistinuria\/\" title=\"Identifiquen un possible biomarcador de l&#8217;aparici\u00f3 de pedres en cistin\u00faria\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/09\/identifiquen-un-possible-biomarcador-de-laparicio-de-pedres-en-cistinuria\/\" title=\"Identifiquen un possible biomarcador de l&#8217;aparici\u00f3 de pedres en cistin\u00faria\">Identifiquen un possible biomarcador de l&#8217;aparici\u00f3 de pedres en cistin\u00faria<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t30\/09\/2021\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/18919\" content=\"Un compost natural, designat medicament orfe per a la cistin\u00faria\" \/><meta itemprop=\"datePublished\" content=\"2021-09-07\" \/><meta itemprop=\"dateModified\" content=\"2021-09-07\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/09\/NO67-Nunes_CIBERER-Imatge-Nunes.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/09\/un-compost-natural-designat-medicament-orfe-per-a-la-cistinuria\/\" title=\"Un compost natural, designat medicament orfe per a la cistin\u00faria\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/09\/un-compost-natural-designat-medicament-orfe-per-a-la-cistinuria\/\" title=\"Un compost natural, designat medicament orfe per a la cistin\u00faria\">Un compost natural, designat medicament orfe per a la cistin\u00faria<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t07\/09\/2021\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/17288\" content=\"IDIBELL celebra el Kickoff Meeting sobre els Projectes d'Investigaci\u00f3 en Salut concedits per l'ISCIII\" \/><meta itemprop=\"datePublished\" content=\"2021-04-20\" \/><meta itemprop=\"dateModified\" content=\"2022-01-11\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/04\/MicrosoftTeams-image.jpg\" \/><meta itemprop=\"width\" content=\"1867\" \/><meta itemprop=\"height\" content=\"1161\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/04\/idibell-celebra-el-kickoff-meeting-sobre-els-projectes-dinvestigacio-en-salut-concedits-per-lisciii\/\" title=\"IDIBELL celebra el Kickoff Meeting sobre els Projectes d'Investigaci\u00f3 en Salut concedits per l'ISCIII\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/04\/idibell-celebra-el-kickoff-meeting-sobre-els-projectes-dinvestigacio-en-salut-concedits-per-lisciii\/\" title=\"IDIBELL celebra el Kickoff Meeting sobre els Projectes d'Investigaci\u00f3 en Salut concedits per l'ISCIII\">IDIBELL celebra el Kickoff Meeting sobre els Projectes d&#8217;Investigaci\u00f3 en Salut concedits per l&#8217;ISCIII<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t20\/04\/2021\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/15902\" content=\"La Marat\u00f3 finan\u00e7ar\u00e0 10 projectes de l'IDIBELL en malalties minorit\u00e0ries amb 1,5 milions d'euros\" \/><meta itemprop=\"datePublished\" content=\"2020-11-30\" \/><meta itemprop=\"dateModified\" content=\"2020-11-30\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2020\/11\/imatge-marato.png\" \/><meta itemprop=\"width\" content=\"680\" \/><meta itemprop=\"height\" content=\"384\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2020\/11\/la-marato-financara-10-projectes-de-lidibell-en-malalties-minoritaries-amb-15-milions-deuros\/\" title=\"La Marat\u00f3 finan\u00e7ar\u00e0 10 projectes de l'IDIBELL en malalties minorit\u00e0ries amb 1,5 milions d'euros\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2020\/11\/la-marato-financara-10-projectes-de-lidibell-en-malalties-minoritaries-amb-15-milions-deuros\/\" title=\"La Marat\u00f3 finan\u00e7ar\u00e0 10 projectes de l'IDIBELL en malalties minorit\u00e0ries amb 1,5 milions d'euros\">La Marat\u00f3 finan\u00e7ar\u00e0 10 projectes de l&#8217;IDIBELL en malalties minorit\u00e0ries amb 1,5 milions d&#8217;euros<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t30\/11\/2020\t\t\t\t\t\t\t\n\t\t<!-- .pp-content-posts -->\n<h2>\n\t\tNot\u00edcies relacionades\n\t<\/h2>\n\n","protected":false},"excerpt":{"rendered":"<p>Gen\u00e8tica molecular humana Resum El grup de gen\u00e8tica molecular humana t\u00e9 com a objectiu principal comprendre millor les bases gen\u00e8tiques i moleculars de les malalties monog\u00e8niques o complexes heredit\u00e0ries i\/o els processos immunoinflamatoris utilitzant estrat\u00e8gies d&#8217;alt rendiment, com ara la gen\u00f2mica, la transcript\u00f2mica i la prote\u00f2mica, aix\u00ed com aproximacions funcionals i estructurals per tal de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":552,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-2642","page","type-page","status-publish","hentry"],"publishpress_future_action":{"enabled":false,"date":"2024-11-30 11:08:48","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2642","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=2642"}],"version-history":[{"count":8,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2642\/revisions"}],"predecessor-version":[{"id":25899,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2642\/revisions\/25899"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/552"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=2642"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}